tag:blogger.com,1999:blog-6141528129298350786.post1501596610164217907..comments2023-10-02T00:49:34.239-07:00Comments on Medical Hemostat: Chinese Starch Medicals Perclot Patent Claims Denied - Impact for Cryolife predictedUnknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-6141528129298350786.post-26790342052481931552013-05-31T14:23:43.722-07:002013-05-31T14:23:43.722-07:00and I quote...."If we sell PerClot in the U.S...and I quote...."If we sell PerClot in the U.S., we will likely be sued for patent infringement, which will be expensive, and if we lose, we may be prohibited from selling PerClot or may have to pay substantial royalties or damages when we sell PerClot, after receiving the FDA’s response to our application. We may not be successful in obtaining regulatory approval to distribute PerClot in the U.S. when expected, if at all."Anonymousnoreply@blogger.com